Literature DB >> 2882202

Hospital-acquired Acinetobacter baumanii pneumonitis.

J F Ygout, B Housset, J P Derenne, G L Daguet.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2882202     DOI： 10.1016/s0140-6736(87)92822-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6).

Authors:  W H Traub; M Spohr
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods.

Authors:  J Tankovic; P Legrand; G De Gatines; V Chemineau; C Brun-Buisson; J Duval
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

3.  Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital.

Authors:  W H Crombach; L Dijkshoorn; M van Noort-Klaassen; J Niessen; G van Knippenberg-Gordebeke
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

4.  Acinetobacter baumannii serotyping for delineation of outbreaks of nosocomial cross-infection.

Authors:  W H Traub
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting.

Authors:  Y Gräser; I Klare; E Halle; R Gantenberg; P Buchholz; H D Jacobi; W Presber; G Schönian
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  A case of Acinetobacter calcoaceticus pneumonia.

Authors:  H Bilgiç; E S Akin; Y Taşan; K Ekiz; O Seber
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.